424 related articles for article (PubMed ID: 9748598)
21. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
[TBL] [Abstract][Full Text] [Related]
22. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
Felix CA; Lange BJ; Hosler MR; Fertala J; Bjornsti MA
Cancer Res; 1995 Oct; 55(19):4287-92. PubMed ID: 7671237
[TBL] [Abstract][Full Text] [Related]
23. Association of CYP3A4 genotype with treatment-related leukemia.
Felix CA; Walker AH; Lange BJ; Williams TM; Winick NJ; Cheung NK; Lovett BD; Nowell PC; Blair IA; Rebbeck TR
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13176-81. PubMed ID: 9789061
[TBL] [Abstract][Full Text] [Related]
24. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias.
von Bergh A; Emanuel B; van Zelderen-Bhola S; Smetsers T; van Soest R; Stul M; Vranckx H; Schuuring E; Hagemeijer A; Kluin P
Genes Chromosomes Cancer; 2000 May; 28(1):14-22. PubMed ID: 10738298
[TBL] [Abstract][Full Text] [Related]
25. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
[TBL] [Abstract][Full Text] [Related]
26. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
27. Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).
Dahéron L; Veinstein A; Brizard F; Drabkin H; Lacotte L; Guilhot F; Larsen CJ; Brizard A; Roche J
Genes Chromosomes Cancer; 2001 Aug; 31(4):382-9. PubMed ID: 11433529
[TBL] [Abstract][Full Text] [Related]
28. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B
Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034
[TBL] [Abstract][Full Text] [Related]
29. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
30. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
31. RAS mutations in pediatric leukemias with MLL gene rearrangements.
Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
[TBL] [Abstract][Full Text] [Related]
32. Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints.
Atlas M; Head D; Behm F; Schmidt E; Zeleznik-Le NH; Roe BA; Burian D; Domer PH
Leukemia; 1998 Dec; 12(12):1895-902. PubMed ID: 9844920
[TBL] [Abstract][Full Text] [Related]
33. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
34. Seminars from the University of Minnesota. Chromosome translocations: dangerous liaisons.
Rowley JD
J Lab Clin Med; 1998 Oct; 132(4):244-50. PubMed ID: 9794694
[TBL] [Abstract][Full Text] [Related]
35. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
36. Topoisomerase II and the etiology of chromosomal translocations.
Felix CA; Kolaris CP; Osheroff N
DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
[TBL] [Abstract][Full Text] [Related]
37. Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia.
Felix CA; Megonigal MD; Chervinsky DS; Leonard DG; Tsuchida N; Kakati S; Block AM; Fisher J; Grossi M; Salhany KI; Jani-Sait SN; Aplan PD
Blood; 1998 Jun; 91(12):4451-6. PubMed ID: 9616138
[TBL] [Abstract][Full Text] [Related]
38. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
Stanulla M; Wang J; Chervinsky DS; Thandla S; Aplan PD
Mol Cell Biol; 1997 Jul; 17(7):4070-9. PubMed ID: 9199342
[TBL] [Abstract][Full Text] [Related]
39. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
Kobayashi Y; Hayashi Y; Ozawa K; Asano S
Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
[TBL] [Abstract][Full Text] [Related]
40. ALL1 gene alterations in acute leukemia: biological and clinical aspects.
Cimino G; Rapanotti MC; Sprovieri T; Elia L
Haematologica; 1998 Apr; 83(4):350-7. PubMed ID: 9592986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]